Get the Stockscreener App
2.57
1.91%
-0.05
After Hours:
2.57
Orchestra Biomed Holdings Inc stock is traded at $2.57, with a volume of 119.27K.
It is down -1.91% in the last 24 hours and down -5.51% over the past month.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$2.62
Open:
$2.62
24h Volume:
119.27K
Relative Volume:
0.37
Market Cap:
$138.66M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-1.7133
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
-6.55%
1M Performance:
-5.51%
6M Performance:
-36.07%
1Y Performance:
-55.54%
1-Day Range:
$2.56
$2.6567
1-Week Range:
$2.56
$2.79
52-Week Range:
$2.37
$6.50
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
2.57 | 140.82M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-20-25 | Initiated | BTIG Research | Buy |
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
What indicators show strength in Orchestra BioMed Holdings Inc.2025 Macro Impact & Low Drawdown Investment Strategies - Newser
Chart based analysis of Orchestra BioMed Holdings Inc. trendsEarnings Recap Report & AI Driven Stock Reports - Newser
What to do if you’re stuck in Orchestra BioMed Holdings Inc.Insider Buying & Daily Entry Point Trade Alerts - Newser
Using portfolio simulators with Orchestra BioMed Holdings Inc. includedMarket Growth Summary & AI Optimized Trade Strategies - Newser
Forecasting Orchestra BioMed Holdings Inc. price range with options dataInflation Watch & High Return Trade Guides - Newser
What Fibonacci levels say about Orchestra BioMed Holdings Inc. reboundJuly 2025 Levels & Stepwise Entry and Exit Trade Signals - Newser
Analyzing Orchestra BioMed Holdings Inc. with risk reward ratio chartsJuly 2025 Trends & Short-Term Swing Trade Alerts - Newser
Has Orchestra BioMed Holdings Inc. formed a bullish divergenceProduct Launch & Safe Entry Trade Signal Reports - Newser
Using data models to predict Orchestra BioMed Holdings Inc. stock movementWeekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Building trade automation scripts for Orchestra BioMed Holdings Inc.Earnings Summary Report & Safe Capital Growth Stock Tips - Newser
Does Orchestra BioMed Holdings Inc. qualify in momentum factor screeningProfit Target & Verified Swing Trading Watchlists - Newser
Heatmap analysis for Orchestra BioMed Holdings Inc. and competitorsJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
Is Orchestra BioMed Holdings Inc. building a consolidation base2025 Historical Comparison & Free Growth Oriented Trading Recommendations - Newser
Does Orchestra BioMed Holdings Inc. fit your quant trading modelQuarterly Trade Summary & Weekly Top Gainers Trade List - Newser
Piper Sandler reiterates Overweight rating on Orchestra BioMed stock - Investing.com
Understanding Orchestra BioMed Holdings Inc.’s price movementTrade Entry Report & Step-by-Step Swing Trade Plans - Newser
Analyzing drawdowns of Orchestra BioMed Holdings Inc. with statistical toolsQuarterly Profit Review & Community Verified Swing Trade Signals - Newser
Price momentum metrics for Orchestra BioMed Holdings Inc. explainedTrade Ideas & Fast Moving Market Watchlists - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
What’s the recovery path for long term holders of Orchestra BioMed Holdings Inc.2025 Market Overview & Risk Managed Investment Entry Signals - Newser
Orchestra BioMed Reports Long-Term Data Supporting AVIM Therapy for Hypertension - MSN
What the charts say about Orchestra BioMed Holdings Inc. todayQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
Is a relief rally coming for Orchestra BioMed Holdings Inc. holdersJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
How to monitor Orchestra BioMed Holdings Inc. with trend dashboardsEarnings Recap Report & Technical Confirmation Trade Alerts - Newser
Analyzing net buyer seller activity in Orchestra BioMed Holdings Inc.Weekly Trend Recap & Comprehensive Market Scan Insights - Newser
Will Orchestra BioMed Holdings Inc. rebound enough to break evenTrade Ideas & Fast Moving Trade Plans - Newser
Smart tools for monitoring Orchestra BioMed Holdings Inc.’s price actionJuly 2025 Drop Watch & Advanced Technical Signal Analysis - Newser
What technical models suggest about Orchestra BioMed Holdings Inc.’s comeback2025 Institutional Moves & Real-Time Stock Movement Alerts - Newser
has orchestra biomed holdings inc. formed a bullish divergenceGold Moves & High Accuracy Investment Signals - Newser
Why Orchestra BioMed Holdings Inc. is moving todaySwing Trade & Real-Time Volume Triggers - Newser
Volatility clustering patterns for Orchestra BioMed Holdings Inc.Earnings Overview Summary & Weekly Watchlist for Consistent Profits - Newser
Is it time to cut losses on Orchestra BioMed Holdings Inc.M&A Rumor & AI Enhanced Market Trend Forecasts - Newser
How to read the order book for Orchestra BioMed Holdings Inc.July 2025 Summary & Reliable Volume Spike Alerts - Newser
HC Wainwright Expects Higher Earnings for Orchestra BioMed - Defense World
Orchestra BioMed Holdings Inc. Attempts Reversal From Key SupportTrade Exit Report & Daily Stock Trend Watchlist - beatles.ru
Orchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA Milestones - MSN
Published on: 2025-09-08 17:50:40 - beatles.ru
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):